Medicine & Life Sciences
Apoptosis
100%
Ovarian Neoplasms
81%
Acute Myeloid Leukemia
69%
Topotecan
66%
Poly(ADP-ribose) Polymerase Inhibitors
63%
Neoplasms
60%
Type I DNA Topoisomerase
50%
tipifarnib
46%
Cell Line
43%
Caspases
42%
Leukemia
42%
Farnesyltranstransferase
35%
Cell Death
34%
Poly(ADP-ribose) Polymerases
34%
Etoposide
34%
Carcinoma
33%
Proteins
33%
Cytarabine
32%
Platinum
30%
Peptides
30%
Camptothecin
30%
Homologous Recombination
30%
alvocidib
29%
NSC 680410
29%
rucaparib
28%
veliparib
27%
In Vitro Techniques
25%
Cisplatin
25%
Type II DNA Topoisomerase
25%
Peptide Hydrolases
24%
Mutation
24%
Drug Therapy
24%
Paclitaxel
24%
Irinotecan
23%
Pharmaceutical Preparations
22%
Antineoplastic Agents
22%
Ligands
22%
Therapeutics
21%
DNA
21%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20%
Phosphotransferases
20%
Breast Neoplasms
19%
lonafarnib
19%
Heterografts
18%
Phosphorylation
18%
Carboplatin
18%
Checkpoint Kinase 1
18%
Poisons
17%
Down-Regulation
17%
Up-Regulation
17%
Chemical Compounds
Apoptotic
52%
Etoposide
28%
Protein
26%
Cell Death
25%
Poly(ADPribose)
20%
Antiapoptotic
20%
Polypeptide
18%
Cleavage
14%
Topotecan
14%
Poison
14%
Resistance
13%
Camptothecin
13%
Antineoplastic Agent
11%
Mutation
10%
Dose
10%
Drug
9%
Imatinib
9%
Refractory
8%
Rucaparib
8%
Phosphotransferase Inhibitor
7%
SN-38
7%
Veliparib
7%
Farnesylation
7%
Reactive Oxygen Metabolite
6%
Cytarabine
6%
Growth Factor
6%
Fragmentation
5%
Proliferative
5%
Colony Stimulating Factor
5%
Histone
5%
Clonogenic
5%